文献速递神经免疫认知障碍与痴呆

儿童获得性脱髓鞘综合征中MOG抗体的预后价值

Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome.
PubMed 文献 · Neurology · 2017-08-02

结果显示MOG抗体主要见于ADEM(57%),高滴度MOG抗体与复发非MS病程相关,且MOG抗体截断滴度≥1:1,280预测非MS病程特异性达100%。

要点

  • MOG抗体在ADEM患儿中阳性率最高(57%),在MS中仅8%。
  • 高MOG抗体滴度与复发非MS病程相关(p=0.0003)。
  • MOG抗体滴度≥1:1,280预测非MS病程特异性100%、敏感性47%。

核心结论

  • MOG抗体的存在与发病年龄密切相关,高MOG抗体滴度与复发非MS病程相关。

主要发现

  • MOG抗体在ADEM中占57%,NMOSD中25%,CIS中25%,MS中8%。
  • 高MOG抗体滴度与较小年龄(p=0.0001)、ADEM诊断(p=0.005)、脑脊液细胞数增高(p=0.011)和OCB阴性(p=0.012)相关。
  • 复发非MS发作与高MOG抗体滴度(p=0.0003)和较大发病年龄(p=0.024)相关;MS由MS样MRI(p<0.0001)和OCB(p=0.007)预测。

关键数值与推荐

  • MOG抗体截断滴度≥1:1,280预测非MS病程的敏感性47%、特异性100%,预测复发非MS病程的敏感性46%、特异性86%。

临床怎么用

  • 在儿童获得性脱髓鞘综合征中,检测MOG抗体有助于鉴别ADEM与非MS病程,高滴度提示复发非MS可能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the prognostic value of MOG antibodies (abs) in the differential diagnosis of acquired demyelinating syndromes (ADS). METHODS: Clinical course, MRI, MOG-abs, AQP4-abs, and CSF cells and oligoclonal bands (OCB) in children with ADS and 24 months of follow-up were reviewed in this observational prospective multicenter hospital-based study. RESULTS: Two hundred ten children with ADS were included and diagnosed with acute disseminated encephalomyelitis (ADEM) (n = 60), neuromyelitis optica spectrum disorder (NMOSD) (n = 12), clinically isolated syndrome (CIS) (n = 101), and multiple sclerosis (MS) (n = 37) after the first episode. MOG-abs were predominantly found in ADEM (57%) and less frequently in NMOSD (25%), CIS (25%), or MS (8%). Increased MOG-ab titers were associated with younger age (p = 0.0001), diagnosis of ADEM (p = 0.005), increased CSF cell counts (p = 0.011), and negative OCB (p = 0.012). At 24-month follow-up, 96 children had no further relapses. Thirty-five children developed recurrent non-MS episodes (63% MOG-, 17% AQP4-abs at onset). Seventy-nine children developed MS (4% MOG-abs at onset). Recurrent non-MS episodes were associated with high MOG-ab titers (p = 0.0003) and older age at onset (p = 0.024). MS was predicted by MS-like MRI (p < 0.0001) and OCB (p = 0.007). An MOG-ab cutoff titer ≥1:1,280 predicted a non-MS course with a sensitivity of 47% and a specificity of 100% and a recurrent non-MS course with a sensitivity of 46% and a specificity of 86%. CONCLUSIONS: Our results show that the presence of MOG-abs strongly depends on the age at disease onset and that high MOG-ab titers were associated with a recurrent non-MS disease course.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Hennes EM, Baumann M, Schanda K, et al. Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome. Neurology. 2017. PMID: 28768844. doi:10.1212/WNL.0000000000004312

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。